To clarify the regulation of drug absorption by the enteric nervous system, we investigated how adrenergic agonists (adrenaline (ADR), clonidine (CLO), dobutamine (DOB)) and dibutyryl cAMP (DBcAMP) affected P-glycoprotein (P-gp) function by utilizing isolated rat jejunal sheets and Caco-2 cell monolayers. ADR and CLO significantly decreased the secretory transport (P) of rhodamine-123 and tended to decrease the transport via P-gp (P) and passive transport (P). In contrast, DBcAMP significantly increased and DOB tended to increase P and both tended to increase Pand P. Changes in P-gp expression on brush border membrane by adrenergic agonists and DBcAMP were significantly correlated with P, while P-gp expression was not changed in whole cell homogenates, suggesting that the trafficking of P-gp would be responsible for its functional changes. P was inversely correlated with transmucosal or transepithelial electrical resistance, indicating that adrenergic agonists affected the paracellular permeability. Adrenergic agonists also changed cAMP levels, which were significantly correlated with P. Furthermore, protein kinase A (PKA) or PKC inhibitor significantly decreased P in Caco-2 cell monolayers, suggesting that they would partly contribute to the changes in P-gp activity. In conclusion, adrenergic agonists regulated P-gp function and paracellular permeability, which would be caused via adrenoceptor stimulation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.xphs.2023.11.010 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!